ENT Devices Market to 2017 - Cochlear Implants and Bone Anchored Hearing Implants are the Fastest Growing Segments

GBI Research
July 6, 2011
77 Pages - SKU: XGBR6444696
License type:
ENT Devices Market to 2017 - Cochlear Implants and Bone Anchored Hearing Implants are the Fastest Growing Segments

Summary

GBI Research’s report, ‘ENT Devices Market to 2017 - Cochlear Implants and Bone Anchored Hearing Implants are the Fastest Growing Segments’ provides key data, information and analysis on the global ENT devices market. The report provides market landscape, competitive landscape and market trends information on four ENT devices market categories: diagnostic devices, hearing aid devices, hearing implants and voice prosthesis. The report provides comprehensive information on the key trends affecting these categories, and key analytical content on the market dynamics. The report also reviews the competitive landscape and gives a detailed analysis of the pipeline products in each category. The report also reviews details regarding important merger and acquisition deals that have taken place in the ENT devices market during the past four years. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts.

Scope
  • Key geographies covered include the US, Canada, the UK, Germany, France, Italy, Spain, Japan, China, India, Australia, and Brazil.
  • Market size for four ENT devices market categories: diagnostic devices, hearing aid devices, hearing implants and voice prosthesis.
  • Annualized market revenues data for 2003-2010, and forecasts for 2010-2017.
  • Qualitative analysis of key market trends, market drivers, and restraints by each category within the ENT devices market.
  • The report also covers information on the leading companies currently operating in the market, the competitive landscape, and the leading technologies.
  • Key players covered include William Demant Holding A/S (WDH), Siemens Healthcare, Cochlear ltd., Sonova Holding.
Reasons to buy
  • Develop business strategies by understanding the trends and developments that are driving the global ENT devices market. Design and develop your product development, marketing and sales strategies.
  • Capitalize on M&A opportunities by identifying key companies with the most innovative pipeline.
  • Develop market entry and market expansion strategies.
  • Identify the key companies that are best positioned to take advantage of emerging market opportunities.
  • Exploit in-licensing and out-licensing opportunities by identifying the products most likely to ensure a robust return.
  • Identify, understand and capitalize on the next being thing in the ENT devices market landscape?
  • Make more informed business decisions from the insightful and in-depth analysis of the ENT devices market and the factors shaping it.



Additional Information

GBI Research’s report, ‘ENT Devices Market to 2017 - Cochlear Implants and Bone Anchored Hearing Implants are the Fastest Growing Segments’ provides key data, information and analysis on the global ENT devices market. The report provides market landscape, competitive landscape and market trends information on four ENT devices market categories: diagnostic devices, hearing aid devices, hearing implants and voice prosthesis. The report provides comprehensive information on the key trends affecting these categories, and key analytical content on the market dynamics. The report also reviews the competitive landscape and gives a detailed analysis of the pipeline products in each category. The report also reviews details regarding important merger and acquisition deals that have taken place in the ENT devices market during the past four years. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts.

ENT Devices Market Forecast to Increase at a CAGR of 7% during 2010-2017

ENT Devices Market, Global, Revenue ($bn), 2010-2017

Source: GBI Research, Company Annual Reports and Interviews with Industry Experts and Key Opinion Leaders

The global ENT (ear, nose and throat) devices market is forecast to exceed $13 billion by 2017, increasing at a compound annual growth rate (CAGR) of 7% during 2010-2017. The ENT devices market is expected to be primarily driven by the increased adoption of technologically advanced equipment. According to the World Health Organization (WHO), January, 2011, about 300 million people worldwide currently suffer from moderate to severe hearing loss, and this number is expected to increase to 700 million by 2015. The percentage of the global population above the age of 60 is expected to rise to 17% by 2030, and as the risk of ENT disorders increases with age, demand for ENT devices is also expected to increase.

William Demant Holding, Sonova Holding AG, Widex and Seimens to Dominate Global ENT Devices Market

ENT Devices Market, Global, Company Share (%), 2010

Source: GBI Research

William Demant Holding A/S (WDH) and Sonova Holding AG are key companies currently operating in the ENT devices industry, with a 14% and 13.5% share of the global ENT devices market respectively. WDH has a diverse product portfolio and generates revenue through the development of products in three categories, namely hearing aids, diagnostic instruments and personal communication. The Oticon, Bernafon and Sonic brands of WDH are the main drivers of growth for the company, and the acquisition of Otix Global has strengthened WDH’s distribution activities and added the Sonic brand to the company’s hearing aid devices product line. Sonova Holding follows WDH with 13.5% share of the global ENT devices market. The company is a market leader in the development of innovative products, the Lyric system-a hearing aid launched by Sonova is invisible to people other than the wearer. Siemens Healthcare; a pioneer in the In The Ear (ITE) hearing aids market holds an 11% share in the global ENT devices market. Siemens Healthcare has launched a number of new products in hearing instruments; the latest in the series is the iMini hearing aid device. Cochlear Ltd. hold a 7.8% share in the global ENT devices market and is a global leader in the hearing implants market. In the future, companies are expected to focus on R&D and explore newer markets, whilst also aggressively marketing existing products.

Hearing Aid Devices to Continue to be the Largest Category in the Global ENT Devices Market

ENT Devices Market, Global, Category Wise Revenue Contribution Share (%), 2010

Source: GBI Research, Company Annual Reports and Interviews with Industry Experts and Key Opinion Leaders

In 2010, the hearing aid devices category emerged as the largest category in the global ENT devices market, accounting for about 86% of the overall ENT devices market. The global hearing aid devices market was valued at $6.6 billion in 2010 and is forecast to grow at a CAGR of 6% to reach $9.9 billion in 2017. An increase in the penetration of hearing aid devices in the US and the UK and technological advances, such as open fir hearing aids, are driving the growth of the hearing aid devices market. In addition, ENT devices market growth has also been stimulated by higher levels of healthcare expenditure in developed economies and an increase in the adoption rate of hearing aid devices.